Finance entity
All 1 tracked stories fall under one category: markets. Contineum Therapeutics is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Finance story that mention Enveric Biosciences, all published on August 24, 2026.
Last mentioned: 1h ago
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: markets. Contineum Therapeutics is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Finance story that mention Enveric Biosciences, all published on August 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Enveric Biosciences. Shared-story counts are live from our verified record — not editorial picks.
A Sunday analyst action shifted two healthcare microcaps from Sell to Hold. CTNM carries a $646.69M valuation and a $20.25 consensus target, while ENVB trades at $1.43 with a $6.41M market cap and negative P/E.
Enveric Biosciences is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
